Subcutaneous ketamine efficacious and safe in treating TRD over a 4-week periodhttps://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/efficacy-and-safety-of-a-4week-course-of-repeated-subcutaneous-ketamine-injections-for-treatmentresistant-depression-kads-study-randomised-doubleblind-activecontrolled-trial/FDBAEC51F0891B57F5B04C572D13DA17 by lysp • 3 years ago 2 0 3 years agoCAcambridge.org